S&P 500   3,337.75 (-1.05%)
DOW   28,992.41 (-0.78%)
QQQ   230.27 (-1.92%)
AAPL   313.05 (-2.26%)
FB   210.18 (-2.05%)
MSFT   178.59 (-3.16%)
GOOGL   1,483.46 (-2.21%)
AMZN   2,095.97 (-2.65%)
CGC   21.88 (-1.93%)
NVDA   294.07 (-4.74%)
BABA   212.59 (-2.50%)
MU   56.99 (-3.41%)
GE   12.25 (-2.23%)
TSLA   901.00 (+0.18%)
AMD   53.28 (-6.97%)
T   38.55 (-0.16%)
ACB   1.67 (-0.60%)
F   7.89 (-1.74%)
NFLX   380.07 (-1.54%)
PRI   132.33 (-2.98%)
BAC   34.36 (-1.41%)
DIS   138.97 (-1.00%)
GILD   69.70 (+4.03%)
S&P 500   3,337.75 (-1.05%)
DOW   28,992.41 (-0.78%)
QQQ   230.27 (-1.92%)
AAPL   313.05 (-2.26%)
FB   210.18 (-2.05%)
MSFT   178.59 (-3.16%)
GOOGL   1,483.46 (-2.21%)
AMZN   2,095.97 (-2.65%)
CGC   21.88 (-1.93%)
NVDA   294.07 (-4.74%)
BABA   212.59 (-2.50%)
MU   56.99 (-3.41%)
GE   12.25 (-2.23%)
TSLA   901.00 (+0.18%)
AMD   53.28 (-6.97%)
T   38.55 (-0.16%)
ACB   1.67 (-0.60%)
F   7.89 (-1.74%)
NFLX   380.07 (-1.54%)
PRI   132.33 (-2.98%)
BAC   34.36 (-1.41%)
DIS   138.97 (-1.00%)
GILD   69.70 (+4.03%)
S&P 500   3,337.75 (-1.05%)
DOW   28,992.41 (-0.78%)
QQQ   230.27 (-1.92%)
AAPL   313.05 (-2.26%)
FB   210.18 (-2.05%)
MSFT   178.59 (-3.16%)
GOOGL   1,483.46 (-2.21%)
AMZN   2,095.97 (-2.65%)
CGC   21.88 (-1.93%)
NVDA   294.07 (-4.74%)
BABA   212.59 (-2.50%)
MU   56.99 (-3.41%)
GE   12.25 (-2.23%)
TSLA   901.00 (+0.18%)
AMD   53.28 (-6.97%)
T   38.55 (-0.16%)
ACB   1.67 (-0.60%)
F   7.89 (-1.74%)
NFLX   380.07 (-1.54%)
PRI   132.33 (-2.98%)
BAC   34.36 (-1.41%)
DIS   138.97 (-1.00%)
GILD   69.70 (+4.03%)
S&P 500   3,337.75 (-1.05%)
DOW   28,992.41 (-0.78%)
QQQ   230.27 (-1.92%)
AAPL   313.05 (-2.26%)
FB   210.18 (-2.05%)
MSFT   178.59 (-3.16%)
GOOGL   1,483.46 (-2.21%)
AMZN   2,095.97 (-2.65%)
CGC   21.88 (-1.93%)
NVDA   294.07 (-4.74%)
BABA   212.59 (-2.50%)
MU   56.99 (-3.41%)
GE   12.25 (-2.23%)
TSLA   901.00 (+0.18%)
AMD   53.28 (-6.97%)
T   38.55 (-0.16%)
ACB   1.67 (-0.60%)
F   7.89 (-1.74%)
NFLX   380.07 (-1.54%)
PRI   132.33 (-2.98%)
BAC   34.36 (-1.41%)
DIS   138.97 (-1.00%)
GILD   69.70 (+4.03%)
Log in

TherapeuticsMD News Headlines (NASDAQ:TXMD)

$2.06
-0.09 (-4.19 %)
(As of 02/21/2020 04:00 PM ET)
Today's Range
$2.02
Now: $2.06
$2.17
50-Day Range
$2.15
MA: $2.40
$2.81
52-Week Range
$1.82
Now: $2.06
$6.09
Volume4.48 million shs
Average Volume3.70 million shs
Market Capitalization$558.62 million
P/E RatioN/A
Dividend YieldN/A
Beta1.65

Headlines

TherapeuticsMD (NASDAQ TXMD) News Headlines

Source:
DateHeadline
TherapeuticsMD Announces Fourth Quarter and Full-Year 2019 Financial Results - Yahoo FinanceTherapeuticsMD Announces Fourth Quarter and Full-Year 2019 Financial Results - Yahoo Finance
finance.yahoo.com - February 21 at 7:41 PM
TherapeuticsMD (NASDAQ:TXMD) Announces Quarterly  Earnings Results, Beats Expectations By $0.01 EPSTherapeuticsMD (NASDAQ:TXMD) Announces Quarterly Earnings Results, Beats Expectations By $0.01 EPS
www.americanbankingnews.com - February 21 at 3:07 PM
HC Wainwright Reiterates Buy Rating for TherapeuticsMD (NASDAQ:TXMD)HC Wainwright Reiterates Buy Rating for TherapeuticsMD (NASDAQ:TXMD)
www.americanbankingnews.com - February 21 at 7:59 AM
TherapeuticsMD Inc (TXMD) Q4 2019 Earnings Call Transcript - Motley FoolTherapeuticsMD Inc (TXMD) Q4 2019 Earnings Call Transcript - Motley Fool
www.fool.com - February 20 at 10:57 PM
TherapeuticsMD Inc (TXMD) Q4 2019 Earnings Call TranscriptTherapeuticsMD Inc (TXMD) Q4 2019 Earnings Call Transcript
www.fool.com - February 20 at 7:16 PM
TherapeuticsMD, Inc. (TXMD) CEO Robert Finizio on Q4 2019 Results - Earnings Call Transcript - Seeking AlphaTherapeuticsMD, Inc. (TXMD) CEO Robert Finizio on Q4 2019 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - February 20 at 5:57 PM
TherapeuticsMD (TXMD) Reports Q4 Loss, Tops Revenue Estimates - Yahoo FinanceTherapeuticsMD (TXMD) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
finance.yahoo.com - February 20 at 5:57 PM
BRIEF-TherapeuticsMD Announces Q4 Loss Per Share Of $0.19 - ReutersBRIEF-TherapeuticsMD Announces Q4 Loss Per Share Of $0.19 - Reuters
www.reuters.com - February 20 at 12:56 PM
TherapeuticsMD, Inc. to Host Earnings Call - Yahoo FinanceTherapeuticsMD, Inc. to Host Earnings Call - Yahoo Finance
finance.yahoo.com - February 20 at 12:56 PM
TherapeuticsMD (TXMD) Reports Q4 Loss, Tops Revenue EstimatesTherapeuticsMD (TXMD) Reports Q4 Loss, Tops Revenue Estimates
finance.yahoo.com - February 20 at 12:56 PM
TherapeuticsMD Announces Fourth Quarter and Full-Year 2019 Financial Results - Business WireTherapeuticsMD Announces Fourth Quarter and Full-Year 2019 Financial Results - Business Wire
www.businesswire.com - February 20 at 7:55 AM
TherapeuticsMD, Inc. to Host Earnings CallTherapeuticsMD, Inc. to Host Earnings Call
finance.yahoo.com - February 20 at 7:55 AM
TherapeuticsMD Announces Fourth Quarter and Full-Year 2019 Financial ResultsTherapeuticsMD Announces Fourth Quarter and Full-Year 2019 Financial Results
finance.yahoo.com - February 20 at 7:55 AM
$13.22 Million in Sales Expected for TherapeuticsMD Inc (NASDAQ:TXMD) This Quarter$13.22 Million in Sales Expected for TherapeuticsMD Inc (NASDAQ:TXMD) This Quarter
www.americanbankingnews.com - February 17 at 4:02 AM
TherapeuticsMD Inc (NASDAQ:TXMD) Given Consensus Rating of "Buy" by BrokeragesTherapeuticsMD Inc (NASDAQ:TXMD) Given Consensus Rating of "Buy" by Brokerages
www.americanbankingnews.com - February 16 at 4:38 AM
 Brokerages Expect TherapeuticsMD Inc (NASDAQ:TXMD) Will Post Earnings of -$0.20 Per Share Brokerages Expect TherapeuticsMD Inc (NASDAQ:TXMD) Will Post Earnings of -$0.20 Per Share
www.americanbankingnews.com - February 15 at 12:43 PM
Earnings Preview: TherapeuticsMD (TXMD) Q4 Earnings Expected to Decline - NasdaqEarnings Preview: TherapeuticsMD (TXMD) Q4 Earnings Expected to Decline - Nasdaq
www.nasdaq.com - February 13 at 11:11 PM
BRIEF-Therapeuticsmd, Afaxys Enter Agreement To Expand Access To Annovera In The U.S. Public Health Sector - ReutersBRIEF-Therapeuticsmd, Afaxys Enter Agreement To Expand Access To Annovera In The U.S. Public Health Sector - Reuters
www.reuters.com - February 13 at 6:10 PM
Earnings Preview: TherapeuticsMD (TXMD) Q4 Earnings Expected to Decline - Yahoo FinanceEarnings Preview: TherapeuticsMD (TXMD) Q4 Earnings Expected to Decline - Yahoo Finance
finance.yahoo.com - February 13 at 6:10 PM
Earnings Preview: TherapeuticsMD (TXMD) Q4 Earnings Expected to DeclineEarnings Preview: TherapeuticsMD (TXMD) Q4 Earnings Expected to Decline
finance.yahoo.com - February 13 at 6:10 PM
TherapeuticsMD up 2% on Annovera access in U.S. public health marketTherapeuticsMD up 2% on Annovera access in U.S. public health market
seekingalpha.com - February 13 at 1:10 PM
Is TherapeuticsMD Stock a Buy?Is TherapeuticsMD Stock a Buy?
www.fool.com - February 13 at 1:10 PM
TherapeuticsMD and Afaxys Enter Into Agreement to Expand Access to ANNOVERA® in the U.S. Public Health Sector - Yahoo FinanceTherapeuticsMD and Afaxys Enter Into Agreement to Expand Access to ANNOVERA® in the U.S. Public Health Sector - Yahoo Finance
finance.yahoo.com - February 13 at 8:10 AM
TherapeuticsMD and Afaxys Enter Into Agreement to Expand Access to ANNOVERA® in the U.S. Public Health SectorTherapeuticsMD and Afaxys Enter Into Agreement to Expand Access to ANNOVERA® in the U.S. Public Health Sector
finance.yahoo.com - February 13 at 8:10 AM
TherapeuticsMD (TXMD) Set to Announce Earnings on ThursdayTherapeuticsMD (TXMD) Set to Announce Earnings on Thursday
www.americanbankingnews.com - February 13 at 3:18 AM
TherapeuticsMD to Report Fourth Quarter 2019 Results on February 20, 2020 - Yahoo FinanceTherapeuticsMD to Report Fourth Quarter 2019 Results on February 20, 2020 - Yahoo Finance
finance.yahoo.com - February 10 at 11:33 AM
TherapeuticsMD to Report Fourth Quarter 2019 Results on February 20, 2020 - Business WireTherapeuticsMD to Report Fourth Quarter 2019 Results on February 20, 2020 - Business Wire
www.businesswire.com - February 10 at 6:33 AM
TherapeuticsMD to Report Fourth Quarter 2019 Results on February 20, 2020TherapeuticsMD to Report Fourth Quarter 2019 Results on February 20, 2020
finance.yahoo.com - February 10 at 6:33 AM
Noble Financial Reaffirms Buy Rating for TherapeuticsMD (NASDAQ:TXMD)Noble Financial Reaffirms Buy Rating for TherapeuticsMD (NASDAQ:TXMD)
www.americanbankingnews.com - February 5 at 7:15 AM
TherapeuticsMD files U.S. application for lower dose of BijuvaTherapeuticsMD files U.S. application for lower dose of Bijuva
seekingalpha.com - February 3 at 5:53 PM
TherapeuticsMD Announces Submission of New Drug Application Prior Approval Efficacy Supplement to the U.S. Food and Drug Administration for Lower Dose of BIJUVA® - Yahoo FinanceTherapeuticsMD Announces Submission of New Drug Application Prior Approval Efficacy Supplement to the U.S. Food and Drug Administration for Lower Dose of BIJUVA® - Yahoo Finance
finance.yahoo.com - February 3 at 7:49 AM
TherapeuticsMD Announces Submission of New Drug Application Prior Approval Efficacy Supplement to the U.S. Food and Drug Administration for Lower Dose of BIJUVA®TherapeuticsMD Announces Submission of New Drug Application Prior Approval Efficacy Supplement to the U.S. Food and Drug Administration for Lower Dose of BIJUVA®
finance.yahoo.com - February 3 at 7:49 AM
TherapeuticsMD Inc (NASDAQ:TXMD) Short Interest Up 9.4% in JanuaryTherapeuticsMD Inc (NASDAQ:TXMD) Short Interest Up 9.4% in January
www.americanbankingnews.com - January 29 at 6:38 AM
Is Quest Diagnostics Stock a Buy? - NasdaqIs Quest Diagnostics Stock a Buy? - Nasdaq
www.nasdaq.com - January 21 at 5:58 PM
Why Beyond Meat Stock Jumped Today - NasdaqWhy Beyond Meat Stock Jumped Today - Nasdaq
www.nasdaq.com - January 21 at 5:58 PM
Why Space ETFs Are Taking Off - NasdaqWhy Space ETFs Are Taking Off - Nasdaq
www.nasdaq.com - January 21 at 5:58 PM
Why TherapeuticsMDs Stock Jumped Today - Motley FoolWhy TherapeuticsMD's Stock Jumped Today - Motley Fool
www.fool.com - January 21 at 5:58 PM
How Much Are TherapeuticsMD, Inc. (NASDAQ:TXMD) Insiders Spending On Buying Shares? - Yahoo FinanceHow Much Are TherapeuticsMD, Inc. (NASDAQ:TXMD) Insiders Spending On Buying Shares? - Yahoo Finance
finance.yahoo.com - January 15 at 1:41 PM
How Much Are TherapeuticsMD, Inc. (NASDAQ:TXMD) Insiders Spending On Buying Shares?How Much Are TherapeuticsMD, Inc. (NASDAQ:TXMD) Insiders Spending On Buying Shares?
finance.yahoo.com - January 15 at 1:41 PM
Form 8-K TherapeuticsMD, Inc. For: Jan 14 - StreetInsider.comForm 8-K TherapeuticsMD, Inc. For: Jan 14 - StreetInsider.com
www.streetinsider.com - January 14 at 5:35 PM
TherapeuticsMDs Business Model Affirms Additional Dilution Is Practically Certain In FY2020 - Seeking AlphaTherapeuticsMD's Business Model Affirms Additional Dilution Is Practically Certain In FY2020 - Seeking Alpha
seekingalpha.com - January 9 at 3:58 PM
TherapeuticsMD, An Innovative Womens Healthcare Company, And PlushCare, A Virtual Health Platform, Announce Enhanced Access To Womens Health Products - PRNewswireTherapeuticsMD, An Innovative Women's Healthcare Company, And PlushCare, A Virtual Health Platform, Announce Enhanced Access To Women's Health Products - PRNewswire
www.prnewswire.com - January 8 at 8:46 PM
TherapeuticsMD, an Innovative Womens Healthcare Company, and PlushCare, a Virtual Health Platform, Announce Enhanced Access to Womens Health Products - Business WireTherapeuticsMD, an Innovative Women's Healthcare Company, and PlushCare, a Virtual Health Platform, Announce Enhanced Access to Women's Health Products - Business Wire
www.businesswire.com - January 7 at 4:29 PM
TherapeuticsMD, an Innovative Women’s Healthcare Company, and PlushCare, a Virtual Health Platform, Announce Enhanced Access to Women’s Health ProductsTherapeuticsMD, an Innovative Women’s Healthcare Company, and PlushCare, a Virtual Health Platform, Announce Enhanced Access to Women’s Health Products
finance.yahoo.com - January 7 at 7:36 AM
TherapeuticsMD, An Innovative Women's Healthcare Company, And PlushCare, A Virtual Health Platform, Announce Enhanced Access To Women's Health ProductsTherapeuticsMD, An Innovative Women's Healthcare Company, And PlushCare, A Virtual Health Platform, Announce Enhanced Access To Women's Health Products
finance.yahoo.com - January 7 at 7:36 AM
TherapeuticsMD Announces Participation at the JP Morgan Healthcare Conference - Business WireTherapeuticsMD Announces Participation at the JP Morgan Healthcare Conference - Business Wire
www.businesswire.com - January 6 at 4:34 PM
TherapeuticsMD Announces Participation at the JP Morgan Healthcare ConferenceTherapeuticsMD Announces Participation at the JP Morgan Healthcare Conference
finance.yahoo.com - January 6 at 4:34 PM
TherapeuticsMD Announces Amendment to Term Loan Financing Facility with TPG Sixth Street Partners - Business WireTherapeuticsMD Announces Amendment to Term Loan Financing Facility with TPG Sixth Street Partners - Business Wire
www.businesswire.com - December 30 at 5:07 PM
TherapeuticsMD Announces Amendment to Term Loan Financing Facility with TPG Sixth Street PartnersTherapeuticsMD Announces Amendment to Term Loan Financing Facility with TPG Sixth Street Partners
finance.yahoo.com - December 30 at 5:07 PM
Do Hedge Funds Love TherapeuticsMD Inc (TXMD)? - Yahoo FinanceDo Hedge Funds Love TherapeuticsMD Inc (TXMD)? - Yahoo Finance
finance.yahoo.com - December 16 at 5:38 PM
This page was last updated on 2/21/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel